Endava ($DAVA) Accounting Review and Internal Controls Case

• $DAVA investors filed a claim against Endava for allegedly failing to disclose concerns about its accounting treatment of certain customer and supplier agreements and the effectiveness of its internal controls.

• After Endava placed its CFO on administrative leave amid an investigation into its accounting treatment of certain agreements, $DAVA fell 24.4% on September 22, 2026, closing at $2.11 per share.

• DAVA investors can join this case to be notified about potential recovery.

Case Details:

Between September 4, 2025, and September 21, 2026, Endava told investors its reported financial results were accurate, and its internal control over financial reporting was effective. Executives emphasized record orders, AI-related growth initiatives, and efforts to build sustainable long-term growth despite a challenging operating environment.

However, during this period, investors allege certain customer and supplier agreements required additional accounting review, and there was reason to doubt the effectiveness of Endava’s internal controls. Endava allegedly failed to disclose that its accounting treatment of certain customer and supplier agreements required additional review, that those accounting concerns would delay the release of its fourth-quarter and full-year 2026 financial results, and that there was reason to doubt the effectiveness of its internal controls and procedures.

Then, on September 21, 2026, Endava revealed that its auditors had raised concerns about the accounting treatment of certain customer and supplier agreements and related matters, prompting an investigation by independent outside counsel for the Audit Committee. The company placed CFO Mark Thurston on administrative leave and appointed Conor McShane as interim CFO.

$DAVA fell $0.68, closing at $2.11 on September 22, 2026, representing a 24.4% decline over the correction period.

Based on these events, $DAVA investors filed a claim against Endava, alleging the company:

• It failed to disclose accounting concerns involving certain customer and supplier agreements.

• It failed to disclose doubts about the effectiveness of its internal controls and procedures.

• It withheld issues that allegedly would delay its fourth-quarter and full-year 2026 financial results.

Investors argue Endava misled the market about its accounting practices and internal controls, causing losses when the truth emerged.